全文获取类型
收费全文 | 704995篇 |
免费 | 42417篇 |
国内免费 | 2833篇 |
专业分类
耳鼻咽喉 | 9481篇 |
儿科学 | 21582篇 |
妇产科学 | 18135篇 |
基础医学 | 111650篇 |
口腔科学 | 20378篇 |
临床医学 | 57651篇 |
内科学 | 134484篇 |
皮肤病学 | 17282篇 |
神经病学 | 50730篇 |
特种医学 | 23278篇 |
外国民族医学 | 80篇 |
外科学 | 98289篇 |
综合类 | 13538篇 |
现状与发展 | 4篇 |
一般理论 | 149篇 |
预防医学 | 59641篇 |
眼科学 | 16972篇 |
药学 | 56175篇 |
23篇 | |
中国医学 | 3338篇 |
肿瘤学 | 37385篇 |
出版年
2021年 | 7404篇 |
2019年 | 7615篇 |
2018年 | 10986篇 |
2017年 | 7674篇 |
2016年 | 8091篇 |
2015年 | 9379篇 |
2014年 | 11885篇 |
2013年 | 17238篇 |
2012年 | 25359篇 |
2011年 | 27377篇 |
2010年 | 15354篇 |
2009年 | 13072篇 |
2008年 | 23946篇 |
2007年 | 25537篇 |
2006年 | 25414篇 |
2005年 | 24375篇 |
2004年 | 22916篇 |
2003年 | 21713篇 |
2002年 | 21109篇 |
2001年 | 29160篇 |
2000年 | 30553篇 |
1999年 | 24822篇 |
1998年 | 6608篇 |
1997年 | 5622篇 |
1996年 | 5837篇 |
1995年 | 5350篇 |
1992年 | 17939篇 |
1991年 | 18271篇 |
1990年 | 18340篇 |
1989年 | 17402篇 |
1988年 | 16130篇 |
1987年 | 15865篇 |
1986年 | 14998篇 |
1985年 | 14279篇 |
1984年 | 10586篇 |
1983年 | 9067篇 |
1979年 | 10453篇 |
1978年 | 7569篇 |
1977年 | 6459篇 |
1976年 | 6259篇 |
1975年 | 7175篇 |
1974年 | 8604篇 |
1973年 | 8143篇 |
1972年 | 7960篇 |
1971年 | 7641篇 |
1970年 | 7067篇 |
1969年 | 6841篇 |
1968年 | 6519篇 |
1967年 | 5867篇 |
1966年 | 5236篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
11.
Amosova E. N. Shilova I. V. Zueva E. P. Rybalkina O. Yu. 《Pharmaceutical Chemistry Journal》2020,54(7):721-724
Pharmaceutical Chemistry Journal - Three extracts were produced from the above-ground part of the meadowsweet Filipendula ulmaria (L.) Maxim. using water, 40% ethanol, and 70% ethanol. Comparative... 相似文献
12.
13.
Jianhui Su Chaoyang Ma Chengxiang Liu Chuanzhong Gao Rongjing Nie 《International journal of food sciences and nutrition》2016,67(1):20-28
This study investigated the hypocholesterolaemic effects of bitter melon aqueous extracts (BMAE) in vitro, the inhibitory effects of BMAE on pancreatic cholesterol esterase (CEase) and incorporation of cholesterol into micelles were investigated. BMAE decreased the in vitro micellar solubility of cholesterol in a dose-dependent manner. The conformation of CEase was investigated by means of circular dichroism (CD) and fluorescence. The result revealed the decrease of α-helix contents, increase of β-sheet and exposure of aromatic amino acid residuals. The incorporation of cholesterol into micelles was inhibited by BMAE. A complex was observed by transmission electron microscopy (TEM), which indicated interaction between cholesterol and BMAE. The result revealed that BMAE can play a role in decreased intestinal cholesterol absorption via inhibition of CEase, and of micelle formation. 相似文献
14.
15.
16.
17.
Past research suggests that as many as 50% of onward human immunodeficiency virus (HIV) transmissions occur during acute and recent HIV infection. It is clearly important to develop interventions which focus on this highly infectious stage of HIV infection to prevent further transmission in the risk networks of acutely and recently infected individuals. Project Protect tries to find recently and acutely infected individuals and prevents HIV transmission in their risk networks. Participants are recruited by community health outreach workers at community-based HIV testing sites and drug users' community venues, by coupon referrals and through referrals from AIDS clinics. When a network with acute/recent infection is identified, network members are interviewed about their risky behaviors, network information is collected, and blood is drawn for HIV testing. Participants are also educated and given prevention materials (condoms, syringes, educational materials); HIV-infected participants are referred to AIDS clinics and are assisted with access to care. Community alerts about elevated risk of HIV transmission are distributed within the risk networks of recently infected. Overall, 342 people were recruited to the project and screened for acute/recent HIV infection. Only six index cases of recent infection (2.3% of all people screened) were found through primary screening at voluntary counseling and testing (VCT) sites, but six cases of recent infection were found through contact tracing of these recently infected participants (7% of network members who came to the interview). Combining screening at VCT sites and contact tracing the number of recently infected people we located as compared to VCT screening alone. No adverse events were encountered. These first results provide evidence for the theory behind the intervention, i.e., in the risk networks of recently infected people there are other people with recent HIV infection and they can be successfully located without increasing stigma for project participants. 相似文献
18.
I. R. Reid 《Journal of internal medicine》2015,277(6):690-706
There is an increasing number of effective therapies for fracture prevention in adults at risk of osteoporosis. However, shortcomings in the evidence underpinning our management of osteoporosis still exist. Evidence of antifracture efficacy in the groups of patients who most commonly use calcium and vitamin D supplements is lacking, the safety of calcium supplements is in doubt, and the safety and efficacy of high doses of vitamin D give cause for concern. Alendronate, risedronate, zoledronate and denosumab have been shown to prevent spine, nonspine and hip fractures; in addition, teriparatide and strontium ranelate prevent both spine and nonspine fractures, and raloxifene and ibandronate prevent spine fractures. However, most trials provide little information regarding long‐term efficacy or safety. A particular concern at present is the possibility that oral bisphosphonates might cause atypical femoral fractures. Observational data suggest that the incidence of this type of fracture increases steeply with duration of bisphosphonate use, resulting in concern that the benefit–risk balance may become negative in the long term, particularly in patients in whom the osteoporotic fracture risk is not high. Therefore, reappraisal of ongoing use of bisphosphonates after about 5 years is endorsed by expert consensus, and ‘drug holidays’ should be considered at this time. Further studies are needed to guide clinical practice in this area. 相似文献
19.
Peng‐fei Lei Shi‐long Su Ling‐yu Kong Cheng‐gong Wang Da Zhong Yi‐he Hu 《Orthopaedic Surgery》2019,11(5):914-920
Three‐dimensional (3D) printing technology, virtual reality, and augmented reality technology have been used to help surgeons to complete complex total hip arthroplasty, while their respective shortcomings limit their further application. With the development of technology, mixed reality (MR) technology has been applied to improve the success rate of complicated hip arthroplasty because of its unique advantages. We presented a case of a 59‐year‐old man with an intertrochanteric fracture in the left femur, who had received a prior left hip fusion. After admission to our hospital, a left total hip arthroplasty was performed on the patient using a combination of MR technology and 3D printing technology. Before surgery, 3D reconstruction of a certain bony landmark exposed in the surgical area was first performed. Then a veneer part was designed according to the bony landmark and connected to a reference registration landmark outside the body through a connecting rod. After that, the series of parts were made into a holistic reference registration instrument using 3D printing technology, and the patient's data for bone and surrounding tissue, along with digital 3D information of the reference registration instrument, were imported into the head‐mounted display (HMD). During the operation, the disinfected reference registration instrument was installed on the selected bony landmark, and then the automatic real‐time registration was realized by HMD through recognizing the registration landmark on the reference registration instrument, whereby the patient's virtual bone and other anatomical structures were quickly and accurately superimposed on the real body of the patient. To the best of our knowledge, this is the first report to use MR combined with 3D printing technology in total hip arthroplasty. 相似文献
20.